$HBIO
HARVARD BIOSCIENCE INC

2021 Q2 Form 10-Q Financial Statement

#000117184321005648 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $29.20M $23.31M $23.77M
YoY Change 25.27% -21.21% -15.71%
Cost Of Revenue $12.84M $9.452M $10.79M
YoY Change 35.89% -30.65% -10.45%
Gross Profit $16.35M $13.86M $12.98M
YoY Change 18.02% -13.16% -19.64%
Gross Profit Margin 56.01% 59.45% 54.61%
Selling, General & Admin $12.13M $9.949M $12.34M
YoY Change 21.91% -5.96% 1.89%
% of Gross Profit 74.17% 71.8% 95.04%
Research & Development $2.701M $1.897M $2.490M
YoY Change 42.38% -31.54% -8.96%
% of Gross Profit 16.52% 13.69% 19.18%
Depreciation & Amortization $1.910M $1.950M $484.0K
YoY Change -2.05% 4.28% -10.04%
% of Gross Profit 11.68% 14.07% 3.73%
Operating Expenses $16.30M $13.30M $16.26M
YoY Change 22.52% -15.43% -0.12%
Operating Profit $58.00K $556.0K -$3.273M
YoY Change -89.57% 143.86% 2627.5%
Interest Expense -$377.0K -$1.233M -$1.299M
YoY Change -69.42% -189.61% -7.54%
% of Operating Profit -650.0% -221.76%
Other Income/Expense, Net -$690.0K -$1.424M -$1.188M
YoY Change -51.54% 4.71% -29.03%
Pretax Income -$632.0K -$868.0K -$4.461M
YoY Change -27.19% -23.32% 148.66%
Income Tax -$200.0K $700.0K $55.00K
% Of Pretax Income
Net Earnings -$410.0K -$1.581M -$4.516M
YoY Change -74.07% 540.08% 90.55%
Net Earnings / Revenue -1.4% -6.78% -19.0%
Basic Earnings Per Share -$0.01 -$0.04 -$0.12
Diluted Earnings Per Share -$0.01 -$0.04 -$0.12
COMMON SHARES
Basic Shares Outstanding 40.15M 38.47K 38.33M
Diluted Shares Outstanding 40.15M 38.47K 38.33M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.237M $2.600M $5.900M
YoY Change 139.88% -46.94% 18.0%
Cash & Equivalents $6.237M $2.629M $5.882M
Short-Term Investments
Other Short-Term Assets $5.220M $3.582M $3.715M
YoY Change 45.73%
Inventory $24.71M $23.18M $23.14M
Prepaid Expenses
Receivables $17.39M $14.71M $15.43M
Other Receivables $5.220M $3.600M $3.700M
Total Short-Term Assets $53.56M $44.10M $48.17M
YoY Change 21.44% -16.0% -10.14%
LONG-TERM ASSETS
Property, Plant & Equipment $3.429M $4.222M $4.488M
YoY Change -18.78% -70.27% -69.47%
Goodwill $58.42M $56.96M $56.79M
YoY Change 2.57% -0.49% -1.02%
Intangibles $30.51M $35.50M $36.81M
YoY Change -14.04%
Long-Term Investments
YoY Change
Other Assets $810.0K $1.743M $1.881M
YoY Change -53.53% 335.75% 25.4%
Total Long-Term Assets $100.4M $106.6M $108.1M
YoY Change -5.79% -6.26% -8.16%
TOTAL ASSETS
Total Short-Term Assets $53.56M $44.10M $48.17M
Total Long-Term Assets $100.4M $106.6M $108.1M
Total Assets $154.0M $150.7M $156.3M
YoY Change 2.18% -9.34% -8.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.489M $6.596M $6.625M
YoY Change 13.54% 9.19% -9.38%
Accrued Expenses $6.522M $7.300M $7.449M
YoY Change -10.66% 10.61% -3.26%
Deferred Revenue $3.675M $3.652M $3.673M
YoY Change 0.63%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.500M $3.200M $3.200M
YoY Change -21.88% 33.33% 45.45%
Total Short-Term Liabilities $23.27M $22.66M $23.48M
YoY Change 2.67% 8.44% -2.59%
LONG-TERM LIABILITIES
Long-Term Debt $40.92M $40.92M $46.28M
YoY Change 0.0% -21.91% -14.45%
Other Long-Term Liabilities $2.538M $870.0K $862.0K
YoY Change 191.72% -91.55% -91.71%
Total Long-Term Liabilities $43.46M $41.79M $47.14M
YoY Change 3.99% -33.35% -26.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.27M $22.66M $23.48M
Total Long-Term Liabilities $43.46M $41.79M $47.14M
Total Liabilities $75.27M $74.62M $80.25M
YoY Change 0.88% -13.14% -11.81%
SHAREHOLDERS EQUITY
Retained Earnings -$133.5M -$130.7M -$129.1M
YoY Change 2.14%
Common Stock $226.0M $231.1M $230.2M
YoY Change -2.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares $0.00 $7.746M $7.746M
Shareholders Equity $78.70M $76.07M $76.01M
YoY Change
Total Liabilities & Shareholders Equity $154.0M $150.7M $156.3M
YoY Change 2.18% -9.34% -8.78%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$410.0K -$1.581M -$4.516M
YoY Change -74.07% 540.08% 90.55%
Depreciation, Depletion And Amortization $1.910M $1.950M $484.0K
YoY Change -2.05% 4.28% -10.04%
Cash From Operating Activities $765.0K $2.370M $2.871M
YoY Change -67.72% 259.09% 42.84%
INVESTING ACTIVITIES
Capital Expenditures -$207.0K -$280.0K $241.0K
YoY Change -26.07% 0.0% 68.53%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$207.0K -$280.0K -$241.0K
YoY Change -26.07% -137.84% 58.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $4.829M
YoY Change 5.37%
Cash From Financing Activities -193.0K -5.300M -$5.071M
YoY Change -96.36% 244.16% 1.34%
NET CHANGE
Cash From Operating Activities 765.0K 2.370M $2.871M
Cash From Investing Activities -207.0K -280.0K -$241.0K
Cash From Financing Activities -193.0K -5.300M -$5.071M
Net Change In Cash 365.0K -3.210M -$2.453M
YoY Change -111.37% 2192.86% -21.95%
FREE CASH FLOW
Cash From Operating Activities $765.0K $2.370M $2.871M
Capital Expenditures -$207.0K -$280.0K $241.0K
Free Cash Flow $972.0K $2.650M $2.630M
YoY Change -63.32% 181.91% 40.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40762931
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40485586
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47152587
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40485586
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39407080
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1500000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2900000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
700000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6237000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8317000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17391000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17766000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
24709000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
22262000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5220000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3355000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
53557000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
51700000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3429000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3960000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7241000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7761000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
58424000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
58590000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30510000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33151000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
810000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1092000 USD
CY2021Q2 us-gaap Assets
Assets
153971000 USD
CY2020Q4 us-gaap Assets
Assets
156254000 USD
CY2021Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
2220000 USD
CY2020Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
1721000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2061000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2111000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7489000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5972000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3675000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3771000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7823000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7478000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23268000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21053000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40921000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46286000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1572000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1899000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6971000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7481000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2538000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2854000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
75270000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
79573000 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
451000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
444000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
225583000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
232357000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133465000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-132386000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13868000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13066000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
-0 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10668000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
78701000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
76681000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
153971000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156254000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29197000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23308000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56186000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47079000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12844000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9452000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24402000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20241000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
16353000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
13856000 USD
us-gaap Gross Profit
GrossProfit
31784000 USD
us-gaap Gross Profit
GrossProfit
26838000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5730000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4279000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11116000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9858000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6399000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5670000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12732000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12429000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2701000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1897000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5188000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4387000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1465000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1454000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2929000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2881000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
16295000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
13300000 USD
us-gaap Operating Expenses
OperatingExpenses
31965000 USD
us-gaap Operating Expenses
OperatingExpenses
29555000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
58000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
556000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-181000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2717000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-377000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1233000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-788000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2532000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-313000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-191000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-347000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-690000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1424000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1135000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2612000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-632000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-868000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1316000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5329000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-222000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
713000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-237000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
768000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-410000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1079000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40152000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38468000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39960000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38389000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-410000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1079000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
523000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
619000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-802000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-957000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
86000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-58000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
523000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-802000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1015000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
113000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-876000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1881000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7112000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
77115000 USD
CY2021Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
-0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
633000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
202000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
526000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1164000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-410000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
523000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
78701000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
76009000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
167000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
769000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76068000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
76681000 USD
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
-0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2557000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
202000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
990000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2132000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1079000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-802000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
78701000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
81694000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
167000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
262000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1562000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1015000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76068000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1079000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
us-gaap Depreciation
Depreciation
891000 USD
us-gaap Depreciation
Depreciation
982000 USD
hbio Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation
AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation
2929000 USD
hbio Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation
AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation
2881000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
140000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
197000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2132000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1562000 USD
hbio Deferred Income Tax Expense Benefit Including Discontinued Operation
DeferredIncomeTaxExpenseBenefitIncludingDiscontinuedOperation
303000 USD
hbio Deferred Income Tax Expense Benefit Including Discontinued Operation
DeferredIncomeTaxExpenseBenefitIncludingDiscontinuedOperation
-423000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-323000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5855000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2526000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1374000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1517000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
601000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1629000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1925000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-100000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-276000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-714000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-233000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1805000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5244000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
357000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
524000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
150000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-507000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-524000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
6115000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
16411000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
102000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2759000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
187000 USD
hbio Net Taxes Paid Net Proceeds From Issuance Of Common Stock
NetTaxesPaidNetProceedsFromIssuanceOfCommonStock
-990000 USD
hbio Net Taxes Paid Net Proceeds From Issuance Of Common Stock
NetTaxesPaidNetProceedsFromIssuanceOfCommonStock
-262000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3333000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10371000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-45000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-55000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2080000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5706000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8317000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8335000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6237000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2629000 USD
us-gaap Interest Paid Net
InterestPaidNet
834000 USD
us-gaap Interest Paid Net
InterestPaidNet
2549000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
168000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
98000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
58590000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-166000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
58424000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
65688000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35426000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30262000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
65679000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32782000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32897000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
248000 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
254000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30510000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33151000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1500000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2900000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2923000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5814000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5704000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5398000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4280000 USD
CY2021Q2 hbio Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
6143000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30262000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5434000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4938000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3758000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3513000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15517000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13811000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
24709000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
22262000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3409000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3715000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
815000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
432000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
237000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
185000 USD
CY2021Q2 hbio Customer Related Costs
CustomerRelatedCosts
1120000 USD
CY2020Q4 hbio Customer Related Costs
CustomerRelatedCosts
1093000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
544000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
286000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1698000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1767000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7823000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7478000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
288000 USD
us-gaap Restructuring Charges
RestructuringCharges
1224000 USD
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
41000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
927000 USD
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
544000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
700000 USD
us-gaap Restructuring Charges
RestructuringCharges
1200000 USD
us-gaap Restructuring Charges
RestructuringCharges
1600000 USD
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
506000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
544000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1023000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1079000 USD
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
55000 USD
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
43000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
101000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
85000 USD
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
26000 USD
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
25000 USD
us-gaap Sublease Income
SubleaseIncome
51000 USD
us-gaap Sublease Income
SubleaseIncome
132000 USD
CY2021Q2 us-gaap Lease Cost
LeaseCost
535000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
562000 USD
us-gaap Lease Cost
LeaseCost
1073000 USD
us-gaap Lease Cost
LeaseCost
1032000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1061000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1381000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
400000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
387000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7241000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7761000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2061000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2111000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6971000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7481000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9032000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9592000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.093 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.093 pure
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1053000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2044000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1999000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1732000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1001000 USD
CY2021Q2 hbio Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4854000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12683000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3651000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9032000 USD
CY2021Q2 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
7745507
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2637339
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
496792
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
609310
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.28
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1531237
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.13
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1164000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
769000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2132000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1562000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7000000.0 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.61
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40152
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38468
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39960
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38389
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40152
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38468
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39960
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38389
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4389966
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5727716
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1259000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1393000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
43141000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
48007000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 USD
CY2021Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
280000 USD
CY2020Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
279000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40921000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46286000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-11000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-227000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-97000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-169000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
86000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-58000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29197000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23308000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56186000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47079000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
325000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29197000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23308000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56186000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47079000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3637000 USD
CY2021Q2 hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1310000 USD
CY2021Q2 hbio Contract With Customer Liability Recognition Of Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfDeferredRevenue
1279000 USD
CY2021Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
7000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3675000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3673000 USD
CY2020Q2 hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1298000 USD
CY2020Q2 hbio Contract With Customer Liability Recognition Of Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfDeferredRevenue
1289000 USD
CY2020Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-30000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3652000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3771000 USD
hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
2902000 USD
hbio Contract With Customer Liability Recognition Of Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfDeferredRevenue
3002000 USD
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
4000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3675000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3949000 USD
hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1829000 USD
hbio Contract With Customer Liability Recognition Of Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfDeferredRevenue
2110000 USD
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-16000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3652000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
227000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-17000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000 USD
hbio Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries
AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries
62000 USD
hbio Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries
AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries
40000 USD
hbio Accounts Receivable Allowance For Credit Loss Effect Of Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossEffectOfForeignCurrencyTranslation
-3000 USD
hbio Accounts Receivable Allowance For Credit Loss Effect Of Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossEffectOfForeignCurrencyTranslation
1000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
145000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
290000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.351 pure
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.821 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.180 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.144 pure

Files In Submission

Name View Source Status
0001171843-21-005648-index-headers.html Edgar Link pending
0001171843-21-005648-index.html Edgar Link pending
0001171843-21-005648.txt Edgar Link pending
0001171843-21-005648-xbrl.zip Edgar Link pending
ex_270460.htm Edgar Link pending
ex_270461.htm Edgar Link pending
ex_270462.htm Edgar Link pending
ex_270463.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hbio-20210630.xsd Edgar Link pending
hbio-20210630_cal.xml Edgar Link unprocessable
hbio-20210630_def.xml Edgar Link unprocessable
hbio-20210630_lab.xml Edgar Link unprocessable
hbio-20210630_pre.xml Edgar Link unprocessable
hboi20210630_10q.htm Edgar Link pending
hboi20210630_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending